Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
暂无分享,去创建一个
B. Nørgård | J. Kjeldsen | M. Larsen | N. Qvist | J. Nielsen | R. Nielsen
[1] S. Snapper,et al. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. , 2014, Gastroenterology.
[2] A. Griffiths,et al. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. , 2014, Journal of Crohn's & colitis.
[3] R. Shamir,et al. Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitis , 2014, Gut.
[4] M. Gilger,et al. Duration of Disease May Predict Response to Infliximab in Pediatric Ulcerative Colitis , 2014, Journal of clinical gastroenterology.
[5] F. Bracci,et al. Is colectomy still an option in the infliximab era? , 2014, Journal of pediatric gastroenterology and nutrition.
[6] S. Dan-Nielsen,et al. Does Infliximab Prevent Colectomy in Acute and Chronic Active Ulcerative Colitis? , 2014, Journal of pediatric gastroenterology and nutrition.
[7] L. Stronati,et al. Advances in the medical management of paediatric IBD , 2014, Nature Reviews Gastroenterology &Hepatology.
[8] N. Afzal,et al. Surgery for children with Crohn's disease: indications, complications and outcome , 2014, Archives of Disease in Childhood.
[9] G. Di Nardo,et al. Disease course and efficacy of medical therapy in stricturing paediatric Crohn's disease. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[10] S. Kugathasan,et al. Incidence, Clinical Characteristics, and Natural History of Pediatric IBD in Wisconsin: a Population-based Epidemiological Study , 2013, Inflammatory bowel diseases.
[11] N. Gupta,et al. Predictors of Proctocolectomy in Children With Ulcerative Colitis , 2012, Journal of pediatric gastroenterology and nutrition.
[12] A. Catto-Smith,et al. The use of biologic agents in pediatric inflammatory bowel disease , 2012, Current opinion in pediatrics.
[13] H. El‐Serag,et al. Natural History of Pediatric-onset Inflammatory Bowel Disease: A Systematic Review , 2012, Journal of clinical gastroenterology.
[14] F. Vasseur,et al. Long‐term outcome of treatment with infliximab in pediatric‐onset Crohn's disease: A population‐based study , 2011, Inflammatory bowel diseases.
[15] T. To,et al. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994–2007)1,2 , 2011, Inflammatory bowel diseases.
[16] Elsebeth Lynge,et al. The Danish National Patient Register , 2011, Scandinavian journal of public health.
[17] David C Wilson,et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.
[18] David C. Wilson,et al. Consensus for Managing Acute Severe Ulcerative Colitis in Children: A Systematic Review and Joint Statement From ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN , 2011, The American Journal of Gastroenterology.
[19] R. Beart,et al. Inflammatory Bowel Disease in the United States from 1998 to 2005: Has Infliximab Affected Surgical Rates? , 2009, The American surgeon.
[20] L. Bardram,et al. Validation of data and indicators in the Danish Cholecystectomy Database. , 2009, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[21] L. Dauchet,et al. The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study , 2009, The American Journal of Gastroenterology.
[22] M. Ottesen. [Validity of the registration and reporting of vaginal prolapse surgery]. , 2009, Ugeskrift for laeger.
[23] David C Wilson,et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. , 2008, Gastroenterology.
[24] K. Murray,et al. Infliximab for Ulcerative Colitis in Children and Adolescents , 2008, Journal of clinical gastroenterology.
[25] A. Griffiths,et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy , 2007, Gut.
[26] A. Griffiths,et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. , 2007, Gastroenterology.
[27] E. Webber,et al. Surgical intervention in children with Crohn’s disease , 2007, International Journal of Colorectal Disease.
[28] A. Griffiths. Specificities of inflammatory bowel disease in childhood. , 2004, Best practice & research. Clinical gastroenterology.
[29] B. Ottesen,et al. Hysterectomy in Denmark. An analysis of postoperative hospitalisation, morbidity and readmission. , 2002, Danish medical bulletin.
[30] Douglas G Altman,et al. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls , 2002, The Lancet.
[31] B. Ottesen,et al. [Evaluation of surgical interventions in Denmark]. , 2001, Ugeskrift for laeger.
[32] T. F. Andersen,et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.
[33] J. Markowitz,et al. Clinical outcome of ulcerative colitis in children. , 1996, The Journal of pediatrics.
[34] H. Sørensen,et al. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. , 1996, Scandinavian journal of gastroenterology.